Mild Cognitive Impairment
Mild cognitive impairment (MCI) is a condition in which a person has noticeable problems with memory, thinking, or other cognitive abilities that are greater than expected for age but not severe enough to significantly interfere with daily life. MCI sits between normal age-related changes and dementia. Some people with MCI remain stable or improve over time, while others go on to develop Alzheimer’s disease or another form of dementia. Identifying contributing causes—such as medications, sleep problems, mood disorders, or vascular and neurodegenerative conditions—is an important part of evaluation.
What is it?
Mild cognitive impairment, or MCI, is a clinical condition in which cognitive abilities such as memory, attention, language, planning, or judgment are clearly worse than expected for a person’s age and education, but not so severely affected that they substantially disrupt independent functioning in daily life. People with MCI are usually still able to manage their own finances, drive, prepare meals, take their medications, and carry out other everyday tasks, though they may need to work harder, use lists or other aids, or take more time than before.
MCI is often divided into two main subtypes based on which abilities are most affected. Amnestic MCI primarily involves memory problems, such as difficulty remembering recent conversations, appointments, or where items were placed. Non-amnestic MCI involves changes in other cognitive areas, such as language (word-finding), executive function (planning, problem-solving), attention, or visuospatial skills, with relatively preserved memory. Some people have impairment in more than one cognitive domain (“multi-domain MCI”). The subtype, along with imaging and laboratory findings, may help suggest the most likely underlying cause.
MCI is not a single disease but a description of cognitive status, and it can have many underlying causes. Some are potentially reversible, including medication side effects (especially from sedatives, anti-anxiety medications, certain antidepressants, and anticholinergic medications), sleep disorders such as obstructive sleep apnea, depression and anxiety, untreated hearing loss, vitamin B12 and other nutritional deficiencies, thyroid dysfunction, alcohol use, chronic stress, and the lingering effects of recent illness or hospitalization. Other causes reflect ongoing brain conditions, such as small-vessel ischemic disease, prior strokes, head injury, normal-pressure hydrocephalus, and early stages of neurodegenerative disorders including Alzheimer’s disease, Lewy body disease, frontotemporal disorders, and Parkinson’s disease–related cognitive changes.
The course of MCI varies. Some people remain stable for years, some improve—particularly when reversible causes are identified and treated—and others gradually progress to dementia. People with amnestic MCI are at higher risk of developing Alzheimer’s disease, especially when imaging shows shrinkage in the hippocampi or biomarker testing reveals evidence of amyloid or tau changes. However, MCI does not guarantee progression to dementia, and many factors influence the path forward.
Evaluation of MCI usually combines a detailed history (from both the patient and a close family member or friend), a neurological examination, and structured cognitive testing. Blood tests are commonly used to look for reversible factors. MRI of the brain helps identify structural causes such as prior strokes, small-vessel disease, hydrocephalus, tumors, or characteristic patterns of atrophy that may suggest specific neurodegenerative conditions. In selected cases, PET imaging (FDG-PET, amyloid PET, or tau PET), cerebrospinal fluid analysis, blood-based biomarkers, or formal neuropsychological testing may be used to clarify the underlying cause.
Important to Know
For people with MCI, the goals of care typically include identifying and treating any contributing factors, supporting cognitive and overall health, monitoring for change over time, and planning thoughtfully for the future. Even when MCI is related to an underlying neurodegenerative disease, much can be done to support function, address mood and sleep, optimize hearing and vision, and reduce vascular risk factors.
Lifestyle measures play an important role. Regular physical activity, cognitive engagement, social interaction, healthy diet, good sleep, treatment of hearing loss, control of blood pressure, diabetes, and cholesterol, and avoidance of excessive alcohol have all been associated with better brain health. Treating depression, anxiety, and chronic stress is also important. Adjusting or discontinuing medications that can worsen cognition (when safely possible and under medical supervision) is often a meaningful step.
In specialized centers, some patients with MCI thought to be due to early Alzheimer’s disease may be candidates for newer disease-modifying therapies, when appropriate based on biomarker testing and overall health. Care is typically coordinated by primary care clinicians, neurologists, geriatricians, and neuropsychologists, often in collaboration with patients and families.
Even when MCI does not progress to dementia, having an evaluation can be valuable. It helps identify reversible causes, supports planning around finances, driving, and future care preferences while the person can fully participate, and provides reassurance through follow-up over time.
Red flag symptoms include sudden severe confusion or memory loss, sudden weakness or numbness, sudden vision changes or difficulty speaking, severe headache, seizures, falls, hallucinations, or rapid worsening of cognition over days to weeks. These warrant urgent medical evaluation, as they may indicate stroke, infection, metabolic disturbance, or another condition that needs immediate attention.